Details of the Drug Inactive Ingredient (DIG)

General Information of DIG (ID: E08SAL)
DIG Name
D&C green no. 5
Synonyms    Click to Show/Hide the Synonyms of This DIG
Acid Green 25; 4403-90-1; Alizarin Cyanine Green F; D&C Green No. 5; Solway Green G; Alizarin Cyanin Green F; C.I. ACID GREEN 25; D & C Green No. 5; Curolite Green G; Ortol Green B; Solway Green GA; Solway Green GN; Erionyl Green GL; Alizarine Green J; Aquamine Green GL; Alizarine Green CE; Alizarine Green CG; Airedale Green ACG; Diachromate Green G; UNII-8J6RDU8L9X; Erio Fast Green GS; Anthraquinone Green G; Tertrochrome Green CG; Neutral Fast Green G; Nylosan Green CP-GL; Fenazo Fast Green AG; Fenazo Fast Green AN; Acid Leather Green AG; Bucacid Fast Green GS; Diacid Light Green GS; Eriosin Fast Green GL; Alizarine Fast Green G; Diacid Cyanine Green G; Anthraquinone Green GNN; Nylomine Acid Green CB; Nylomine Acid Green PG; Acid Green Anthraquinone; Green No. 201; Kayanol Cyanine Green G; Alizarine Fast Green CG; Alizarine Fast Green GN; Coomassie Fast Green GN; Coomassie Fast Green GW; Alizarin Cyanine Green G; Synchromate Fast Green B; Alizarine Light Green GS; Neutral Cyanine Green GN; Tertracid Light Green CG; Alizarine Fast Green CGN; Chrome Green Anthraquinone; 11359 Green; Alizarine Cyanine Green G; Alizarine Cyanone Green G; D and C Green No. 5; Alizarine Light Green GNS; Alizarine Light Green GSN; Alizarine Cyanine Green CG; Alizarine Cyanone Green GN; Alizarine Neutral Green CE; Alizarine Neutral Green CG; Erio Fast Cyanine Green G; Synchromate Fast Green GGW; Ahcoquinone Cyanine Green G; Alizarine Brilliant Green G; Calcocid Alizarine Green CG; Ahcoquinone Cyanine Green GN; Alizarine Brilliant Green EF; Calcocid Alizarine Green CGN; Suminol Fast Cyanine Green G; Alizarine Cyanine Green G-CF; Mitsui Alizarine Fast Green GX; Alizarine Cyanine Green GHN-CF; Alizarine Fast Printing Green G; 8J6RDU8L9X; Kayaku Alizarine Cyanine Green G; Mitsui Alizarine Cyanine Green G; Shimazaki Nylon Cyanine Green GN; Belacid Alizarine Cyanine Green GN; C.I. 61570; NSC 7795; C.I. Acid Green 25 disodium salt; Shimazaki Alizarine Cyanine Green GS; CI 61570; MFCD00001193; 2,2'-(1,4-Anthraquinonylenediimino)bis(5-methylbenzenesulfonic acid) disodium salt; Alizarine Cyanone Green B (Biological stain); Zelen alizarinova brilantni g-extra; Benzenesulfonic acid, 2,2'-((9,10-dihydro-9,10-dioxo-1,4-anthracenediyl)diimino)bis(5-methyl-, sodium salt (1:2); C.I. 61 570; Alizarine Green G (VAN); Zelen kysela 25 [Czech]; Zelen kysela 25; Sodium 6,6'-((9,10-dioxo-9,10-dihydroanthracene-1,4-diyl)bis(azanediyl))bis(3-methylbenzenesulfonate); Alizarine Direct Green G (VAN); D&C Green 5; C.I. 61 570 [Czech]; EINECS 224-546-6; NSC 41838; Zelen alizarinova brilantni G-extra [Czech]; HSDB 8005; Disodium 2,2'-(9,10-dioxoanthracene-1,4-diyldiimino)bis(5-methylsulphonate); Alizarin cyanin green; 1,4-Bis(o-sulfo-p-toluino)anthraquinone, disodium salt; ACIDGREEN25; C.I.Acid Green 25; D & C green 5; Benzenesulfonic acid, 2,2'-((9,10-dihydro-9,10-dioxo-1,4-anthracenediyl)diimino)bis(5-methyl-, disodium salt; SCHEMBL126076; C28H20N2Na2O8S2; DTXSID2024903; Acid Green 25, analytical standard; AKOS004901477; AKOS015902977; AKOS024319051; Acid Green 25, Dye content >=60 %; Benzenesulfonic acid, 2,2'-(1,4-anthraquinonylenediimino)bis(5-methyl-, disodium salt; O843; Alizarin Cyanin Green G (C.I. 61570); A0610; ACID GREEN 25 (C.I. 61570); FT-0621851; C20337; Q27270622; Acid Green 25;Disodium 2,2'-(9,10-dioxoanthracene-1,4-diyldiimino)bis(5-methylsulphonate); m-Toluenesulfonic acid, 6,6'-(1,4-anthraquinonylenediimino)di-, disodium salt (8CI); sodium 6,6'-(9,10-dioxo-9,10-dihydroanthracene-1,4-diyl)bis(azanediyl)bis(3-methylbenzenesulfonate)
DIG Function
Colorant
PubChem CID
20431
Formula
C28H20N2Na2O8S2
Canonical SMILES
CC1=CC(=C(C=C1)NC2=C3C(=C(C=C2)NC4=C(C=C(C=C4)C)S(=O)(=O)[O-])C(=O)C5=CC=CC=C5C3=O)S(=O)(=O)[O-].[Na+].[Na+]
InChI
1S/C28H22N2O8S2.2Na/c1-15-7-9-19(23(13-15)39(33,34)35)29-21-11-12-22(30-20-10-8-16(2)14-24(20)40(36,37)38)26-25(21)27(31)17-5-3-4-6-18(17)28(26)32;;/h3-14,29-30H,1-2H3,(H,33,34,35)(H,36,37,38);;/q;2*+1/p-2
InChIKey
FPAYXBWMYIMERV-UHFFFAOYSA-L
   Click to Show/Hide the Molecular Data (Structure/Property) of This DIG
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=20431"></iframe>
3D MOL is not available 2D MOL
Physicochemical Properties Molecular Weight 622.6 Topological Polar Surface Area 189
XlogP N.A. Complexity 1060
Heavy Atom Count 42 Rotatable Bond Count 4
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 10
Full List of Active Pharmaceutical Ingredients (APIs) Co-administrated with This DIG
       ICD Disease Classification 06 Mental/behavioural/neurodevelopmental disorder Click to Show/Hide
Risperidone
 API Info
Schizophrenia [ICD-11: 6A20]
 [1]
       ICD Disease Classification 11 Circulatory system disease Click to Show/Hide
Digoxin
 API Info
Cardiac arrhythmia [ICD-11: BC65]
 [2]
Full List of Biological Targets of DIG (DBTs) Regulated by This DIG
      G-protein coupled receptor (GPCR)
            DBT Name: P2Y purinoceptor 2 (P2RY2) Click to Show/Hide
               Detailed Information DBT Info click to show the detail info of this DBT
               Experiment (1) for Assessing the Biological Activity of the Studied DIG on This DBT
                    Biological Activity IC50 = 3930 nM (estimated based on the structural similarity with CHEMBL401859 ) [3]
                    Structural Similarity Tanimoto coefficient = 0.934131737
                    Tested Species Homo sapiens (Human)
                    UniProt ID P2RY2_HUMAN
               Experiment (2) for Assessing the Biological Activity of the Studied DIG on This DBT
                    Biological Activity IC50 = 30000 nM (estimated based on the structural similarity with CHEMBL401859 ) [3]
                    Structural Similarity Tanimoto coefficient = 0.934131737
                    Tested Species Mus musculus (Mouse)
                    UniProt ID P2RY2_MOUSE
            DBT Name: P2Y purinoceptor 4 (P2RY4) Click to Show/Hide
               Detailed Information DBT Info click to show the detail info of this DBT
               Experiment for Assessing the Biological Activity of the Studied DIG on This DBT
                    Biological Activity IC50 = 1910 nM (estimated based on the structural similarity with CHEMBL401859 ) [4]
                    Structural Similarity Tanimoto coefficient = 0.934131737
                    Tested Species Homo sapiens (Human)
                    UniProt ID P2RY4_HUMAN
      Potential-driven transporter (PDT)
            DBT Name: Solute carrier SLCO2B1 (OATPB) Click to Show/Hide
               Detailed Information DBT Info click to show the detail info of this DBT
               Experiment (1) for Assessing the Biological Activity of the Studied DIG on This DBT
                    Biological Activity Inhibition ratio = 89 % (tested by experiment) [5]
                    Tested Species Homo sapiens (Human)
                    UniProt ID SO2B1_HUMAN
               Experiment (2) for Assessing the Biological Activity of the Studied DIG on This DBT
                    Biological Activity Ki = 1.54 uM (tested by experiment) [5]
                    Tested Species Homo sapiens (Human)
                    UniProt ID SO2B1_HUMAN
References
1 FDA label for approved risperidone from the official website of the U.S. Food and Drug Administration.
2 FDA label for approved digoxin from the official website of the U.S. Food and Drug Administration.
3 Combinatorial synthesis of anilinoanthraquinone derivatives and evaluation as non-nucleotide-derived P2Y2 receptor antagonists. Bioorg Med Chem Lett. 2008 Jan 1; 18(1):223-7.
4 Development of Potent and Selective Antagonists for the UTP-Activated P2Y 4 Receptor. J Med Chem. 2017 Apr 13; 60(7):3020-3038.
5 Bacterial metabolism rescues the inhibition of intestinal drug absorption by food and drug additives. Proc Natl Acad Sci U S A. 2020 Jul 7;117(27):16009-16018.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.